Current diagnosis and management of erectile dysfunction

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) is a prevalent condition impacting male sexual health and overall quality of life.
• Associated factors include aging, obesity, diabetes, hypertension, and cardiovascular disease.
• ED can also be linked to lower urinary tract symptoms from benign prostatic hyperplasia.

Purpose of the Study:

• To outline the diagnostic evaluation for men presenting with ED.
• To review current therapeutic strategies for managing ED.
• To discuss the efficacy of various ED treatment modalities.

Main Methods:

• Comprehensive medical and sexual history taking.
• Focused clinical examination.
• Laboratory tests including fasting glucose, lipid profile, and potentially testosterone and PSA levels.

Main Results:

• Phosphodiesterase type 5 inhibitors (PDE5i) like sildenafil and tadalafil are effective in 60-65% of men with ED, including those with comorbidities.
• Intracorporal injections with alprostadil offer an alternative for non-responders to oral medications.
• Penile implants provide high satisfaction rates, while arterial revascularization and venous ligation show less favorable outcomes.

Conclusions:

• ED management requires a tailored approach combining lifestyle modifications, risk factor reduction, and targeted therapies.
• Pharmacotherapy (PDE5i), intracavernosal injections, and surgical implants are established treatment options.
• Surgical interventions like penile implants offer high success rates, contrasting with revascularization procedures for specific vascular ED types.